Cargando…

Cinobufagin suppresses colorectal cancer angiogenesis by disrupting the endothelial mammalian target of rapamycin/hypoxia‐inducible factor 1α axis

Inducing angiogenesis is a hallmark of cancers that sustains tumor growth and metastasis. Neovascularization is a surprisingly early event during the multistage progression of cancer. Cinobufagin, an important bufadienolide originating from Chan Su, has been clinically used to treat cancer in China...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Xiaowu, Chen, Chunhui, Dai, Yu, Huang, Chengzhi, Han, Qinrui, Jing, Linlin, Ma, Ye, Xu, Yihua, Liu, Yawei, Zhao, Liang, Wang, Junjiang, Sun, Xuegang, Yao, Xueqing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6501006/ https://www.ncbi.nlm.nih.gov/pubmed/30839155 http://dx.doi.org/10.1111/cas.13988

Ejemplares similares

Sanguinarine triggers intrinsic apoptosis to suppress colorectal cancer growth through disassociation between STRAP and MELK
por: Gong, Xianling, et al.
Publicado: (2018)

Pharmacological Effects of Cinobufagin
por: Zhang, Hao, et al.
Publicado: (2023)

Immunomodulatory Effects of Cinobufagin on Murine Lymphocytes and Macrophages
por: Yu, Yang, et al.
Publicado: (2015)

Resibufogenin suppresses colorectal cancer growth and metastasis through RIP3-mediated necroptosis
por: Han, Qinrui, et al.
Publicado: (2018)

Girdin knockdown promotes apoptosis in colorectal cancer via miR-29c-3p/Girdin axis
por: Wang, Junjiang, et al.
Publicado: (2019)

Cinobufagin Suppresses Melanoma Cell Growth by Inhibiting LEF1
por: Kim, Geon-Hee, et al.
Publicado: (2020)

Antifibrotic Mechanism of Cinobufagin in Bleomycin-Induced Pulmonary Fibrosis in Mice
por: Li, Xiaohe, et al.
Publicado: (2019)

Resibufogenin and Cinobufagin Activate Central Neurons through an Ouabain-Like Action
por: Wang, Ze-Jun, et al.
Publicado: (2014)

Cinobufagin Modulates Human Innate Immune Responses and Triggers Antibacterial Activity
por: Xie, Shanshan, et al.
Publicado: (2016)

Preclinical study of cinobufagin as a promising anti-colorectal cancer agent
por: Lu, Xing-sheng, et al.
Publicado: (2016)

The Mammalian Target of Rapamycin and DNA methyltransferase 1 axis mediates vascular endothelial dysfunction in response to disturbed flow
por: Zhang, Yun-Peng, et al.
Publicado: (2017)

Mammalian Target of Rapamycin Inhibitors Induce Tumor Cell Apoptosis In Vivo Primarily by Inhibiting VEGF Expression and Angiogenesis
por: Frost, Patrick, et al.
Publicado: (2013)

Hinokitiol impedes tumor drug resistance by suppressing protein kinase B/mammalian targets of rapamycin axis
por: Ni, Ying-Jui, et al.
Publicado: (2022)

The synergistic antitumor effect of cinobufagin and cisplatin in human osteosarcoma cell line in vitro and in vivo
por: Dai, Guo, et al.
Publicado: (2017)

Spatial Lipidomics Reveals Anticancer Mechanisms of Bufalin in Combination with Cinobufagin in Tumor-Bearing Mice
por: Zhang, Jinghui, et al.
Publicado: (2021)

Rheb and mammalian target of rapamycin in mitochondrial homoeostasis
por: Groenewoud, Marlous J., et al.
Publicado: (2013)

Study of Cinobufagin as a Promising Anticancer Agent in Uveal Melanoma Through Intrinsic Apoptosis Pathway
por: Zhang, Leilei, et al.
Publicado: (2020)

Cinobufagin inhibits tumor growth by inducing apoptosis through Notch signaling pathways in human cholangiocarcinoma
por: Ren, Jiajun, et al.
Publicado: (2019)

Cinobufagin Is a Selective Anti-Cancer Agent against Tumors with EGFR Amplification and PTEN Deletion
por: He, Kunyan, et al.
Publicado: (2021)

Acetyl-cinobufagin suppresses triple-negative breast cancer progression by inhibiting the STAT3 pathway
por: Qi, Yufeng, et al.
Publicado: (2023)

Inhibition of mammalian target of rapamycin by rapamycin increases the radiosensitivity of esophageal carcinoma Eca109 cells
por: ZHANG, DEJUN, et al.
Publicado: (2014)

Mammalian target of rapamycin inhibitors for treatment in tuberous sclerosis
por: Kim, Won Seop
Publicado: (2011)

SIRT1 Negatively Regulates the Mammalian Target of Rapamycin
por: Ghosh, Hiyaa Singhee, et al.
Publicado: (2010)

Mammalian target of rapamycin signaling in diabetic cardiovascular disease
por: Chong, Zhao Zhong, et al.
Publicado: (2012)

Driving neural regeneration through the mammalian target of rapamycin
por: Maiese, Kenneth
Publicado: (2014)

Therapeutic control of leishmaniasis by inhibitors of the mammalian target of rapamycin
por: Khadir, Fatemeh, et al.
Publicado: (2018)

Autism Spectrum Disorder and Mammalian Target of Rapamycin System
por: Posar, Annio, et al.
Publicado: (2020)

Crosstalk of the Caspase Family and Mammalian Target of Rapamycin Signaling
por: Yan, Junfang, et al.
Publicado: (2021)

Advanced retinoblastoma treatment: targeting hypoxia by inhibition of the mammalian target of rapamycin (mTOR) in LH(BETA)T(AG) retinal tumors
por: Piña, Y, et al.
Publicado: (2011)

Combining the mammalian target of rapamycin inhibitor, rapamycin, with resveratrol has a synergistic effect in multiple myeloma
por: Jin, Hong-Guang, et al.
Publicado: (2018)

Rapamycin protects against aristolochic acid nephropathy in mice by potentiating mammalian target of rapamycin-mediated autophagy
por: Lin, Fan, et al.
Publicado: (2021)

Cinobufagin Suppresses The Characteristics Of Osteosarcoma Cancer Cells By Inhibiting The IL-6-OPN-STAT3 Pathway
por: Zhang, Chuan, et al.
Publicado: (2019)

Cinobufagin-Loaded and Folic Acid-Modified Polydopamine Nanomedicine Combined With Photothermal Therapy for the Treatment of Lung Cancer
por: Li, Jianwen, et al.
Publicado: (2021)

Cinobufagin Exerts Anticancer Activity in Oral Squamous Cell Carcinoma Cells through Downregulation of ANO1
por: Jo, Sungwoo, et al.
Publicado: (2021)

Cinobufagin exerts an antitumor effect in non-small-cell lung cancer by blocking STAT3 signaling
por: Yan, Sunshun, et al.
Publicado: (2023)

Mammalian Tribbles Homologs at the Crossroads of Endoplasmic Reticulum Stress and Mammalian Target of Rapamycin Pathways
por: Cunard, Robyn
Publicado: (2013)

Stathmin Regulates Hypoxia-Inducible Factor-1α Expression through the Mammalian Target of Rapamycin Pathway in Ovarian Clear Cell Adenocarcinoma
por: Tamura, Kazuhiro, et al.
Publicado: (2013)

Mammalian target of rapamycin and head and neck squamous cell carcinoma
por: Liao, Yu-Min, et al.
Publicado: (2011)

Mammalian Target of Rapamycin: Hitting the Bull's-Eye for Neurological Disorders
por: Chong, Zhao Zhong, et al.
Publicado: (2010)

New Developments in Mammalian Target of Rapamycin Inhibitors for the Treatment of Sarcoma
por: Agulnik, Mark
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_n6ogb4o3641r6cf19u4svrgbro